2026-10-23T16:04:34Zhttps://gumushane-rdlopen.rawdatalibrary.net/oai/request

oai:gumushane-rdlopen.rawdatalibrary.net:gumushane/153912026-10-22T11:29:53Zopenairedrivercom_gumushane_10000col_gumushane_10001com_gumushane_10010col_gumushane_10182

N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes i and IIYildirim, AlperAtmaca, UfukKeskin, AliTopal, MeryemÇelik, MuratGülçin, IlhamiSupuran, Claudiu T.Carbonic anhydraseEnzyme inhibitionEnzyme purificationImideN-AcylsulfonamideSulfonamideSulfonamides represent a significant class of biologically active compounds that inhibit carbonic anhydrase (CA, EC.: 4.2.1.1) isoenzymes involved in different pathological and physiological events. Sulfonamide CA inhibitors are used therapeutically as diuretic, antiglaucoma, antiobesity and anticancer agents. A series of new sulfonamides were synthesized using imides and tosyl chloride as starting materials. These N-acylsulfonamides efficiently inhibited the cytosolic human carbonic anhydrase isoenzymes I, and II (hCA I, and II), with nanomolar range inhibition constants ranging between 36.4 ± 6.0-254.6 ± 18.0 and 58.3 ± 0.6-273.3 ± 2.5 nM, respectively.Elsevier Ltd2015Articlehttps://rdlopen.rawdatalibrary.net/r/gumushane/15391https://doi.org/10.1016/j.bmc.2014.12.0540968-0896enBioorganic and Medicinal Chemistryinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://gumushane-rdlopen.rawdatalibrary.net/tr/items/gumushane/15391